2019
DOI: 10.2217/bmm-2018-0451
|View full text |Cite
|
Sign up to set email alerts
|

Association of Monocyte-To-High Density Lipoprotein-Cholesterol Ratio with Peripheral Neuropathy in Patients with Type Ii Diabetes Mellitus

Abstract: Aim: We assessed the association of monocyte count to high-density lipoprotein cholesterol ratio (MHR) with diabetic peripheral neuropathy (DPN) and its role as a marker for identification of high-risk patients for DPN. Methods: A total of 180 patients with Type II diabetes mellitus (T2DM) were enrolled in the study. MHR, erythrocyte sedimentation rate and serum CRP along with other tests for T2DM and DPN were measured. Results: Duration of T2DM (p = 0.013), insulin use (p = 0.006) and serum CRP levels (p = 0.… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
3
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 14 publications
(5 citation statements)
references
References 32 publications
0
3
0
Order By: Relevance
“…Most recently, considering the pro-inflammatory properties of monocytes and the anti-inflammatory properties of high-density lipoprotein (HDL), the ratio of monocyte to HDL-cholesterol (MHR) has been viewed as a novel systemic inflammatory marker used in clinical applications. Some studies show that MHR is associated with metabolic syndrome ( 15 ), acute coronary syndrome ( 16 ), and T2DM ( 17 , 18 ). MHR has been shown to be an independent predictor of carotid artery disease in acute ischemic stroke ( 19 ) and diabetic retinopathy in T2DM patients ( 20 ).…”
Section: Introductionmentioning
confidence: 99%
“…Most recently, considering the pro-inflammatory properties of monocytes and the anti-inflammatory properties of high-density lipoprotein (HDL), the ratio of monocyte to HDL-cholesterol (MHR) has been viewed as a novel systemic inflammatory marker used in clinical applications. Some studies show that MHR is associated with metabolic syndrome ( 15 ), acute coronary syndrome ( 16 ), and T2DM ( 17 , 18 ). MHR has been shown to be an independent predictor of carotid artery disease in acute ischemic stroke ( 19 ) and diabetic retinopathy in T2DM patients ( 20 ).…”
Section: Introductionmentioning
confidence: 99%
“…Therefore, the monocyte count–to–HDL-C ratio (MHR) can reflect the inflammatory status and is related to the development of disease associated with chronic inflammation. The MHR has been found to be associated with the occurrence and prognosis of cardiovascular diseases (CVDs), diabetic nephropathy and diabetic peripheral neuropathy ( 14 17 ). However, to the best of our knowledge, there are a few studies with small sample size that evaluated the associations of the MHR with DR and got contradictory conclusion ( 18 , 19 ).…”
Section: Introductionmentioning
confidence: 99%
“…Monocytes and macrophages aggregate at the site of inflammation and release inflammatory cytokines, leading to acute vascular inflammation. This damages the endothelial cells of the blood vessels and promotes thrombus formation [ 24 ].…”
Section: Discussionmentioning
confidence: 99%